Impact of decreasing vancomycin exposure on acute kidney injury in stem cell transplant recipients.

Horace Rhodes HambrickKimberly F GrecoEdie WellerLakshmi GanapathiLeslie E LehmannThomas J Sandora

Published in: Infection control and hospital epidemiology (2021)

An ASP intervention successfully decreased vancomycin use after HSCT and resulted in a decrease in AKI. Reducing empiric antibiotic exposure for stable patients after HSCT can improve clinical outcomes.

Keyphrases

stem cells
end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
methicillin resistant staphylococcus aureus
chronic kidney disease
acute kidney injury
prognostic factors
peritoneal dialysis
mesenchymal stem cells
bone marrow
staphylococcus aureus
patient reported outcomes